sr 48692 has been researched along with spc-839 in 1 studies
| Studies (sr 48692) | Trials (sr 48692) | Recent Studies (post-2010) (sr 48692) | Studies (spc-839) | Trials (spc-839) | Recent Studies (post-2010) (spc-839) |
|---|---|---|---|---|---|
| 203 | 3 | 36 | 37 | 0 | 18 |
| Protein | Taxonomy | sr 48692 (IC50) | spc-839 (IC50) |
|---|---|---|---|
| Inhibitor of nuclear factor kappa-B kinase subunit beta | Homo sapiens (human) | 0.0538 | |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | Homo sapiens (human) | 1.3 | |
| Transcription factor AP-1 | Homo sapiens (human) | 0.008 | |
| Nuclear factor NF-kappa-B p105 subunit | Homo sapiens (human) | 0.008 | |
| Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.344 | |
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.2527 | |
| Receptor-type tyrosine-protein kinase FLT3 | Homo sapiens (human) | 0.618 | |
| Nuclear factor NF-kappa-B p100 subunit | Homo sapiens (human) | 0.008 | |
| Transcription factor p65 | Homo sapiens (human) | 0.008 | |
| Cannabinoid receptor 2 | Rattus norvegicus (Norway rat) | 0.344 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
1 other study(ies) available for sr 48692 and spc-839
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |